獣医感染症診断市場 – 2030年までの世界予測

本市場調査は、獣医感染症診断市場を様々なセグメントにわたって網羅しています。製品、技術、動物種、エンドユーザー、地域別に市場規模と成長ポテンシャルを推定することを目的としています。また、主要企業の詳細な競合分析に加え、企業概要、製品および事業内容に関する主要な考察、最近の動向、主要な市場戦略も提供しています。

獣医感染症診断市場は、2025年の28億7,000万米ドルから2030年には42億2,000万米ドルへと、年平均成長率8.0%で成長すると予測されています。この成長は、動物の健康と疾病管理を取り巻く環境の変化を反映した、いくつかの重要な要因によって推進されています。

The veterinary infectious disease diagnostics market is expected to grow from USD 2.87 billion in 2025 to USD 4.22 billion by 2030, at a CAGR of 8.0%. This growth is driven by several important factors that reflect the changing landscape of animal health and disease management.

One primary driver is the increasing burden of infectious diseases among both companion animals and livestock, which has heightened the need for rapid, reliable, and field-deployable diagnostic solutions. The rise in outbreaks of diseases such as avian influenza, leptospirosis, and brucellosis is leading veterinarians and animal producers to prioritize early and accurate detection to mitigate risks.

Another significant factor is the shift towards preventive veterinary care. As awareness grows among pet owners and livestock handlers, there is a stronger emphasis on routine screenings and health monitoring to identify infections before they escalate. This trend is also supported by a growing recognition of the economic and public health consequences associated with the transmission of zoonotic diseases.

“By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period.”

The companion animals segment is expected to see the highest growth in the veterinary infectious disease diagnostics market, driven by increasing pet ownership, especially in urban high-income households. Pet owners are more willing to invest in health check-ups and diagnostic services due to the growing awareness of zoonotic diseases and the importance of early detection. Additionally, innovations in point-of-care and home-based diagnostic tools enhance access for both pet owners and veterinarians. With more frequent visits to veterinary clinics and rising healthcare spending for pets, this segment is projected for rapid growth in the market.

“By technology, the immunodiagnostics segment accounted for the largest market share in 2024.”

In 2024, the immunodiagnostics segment dominated the veterinary infectious disease diagnostics market due to its cost-effectiveness and high accuracy. Techniques like ELISA and lateral flow assays are commonly used to detect various infectious diseases in companion and livestock animals. These tests provide rapid results, are user-friendly, and require minimal equipment, making them ideal for veterinary clinics and field use. Their ability to detect specific antigens or antibodies enables early diagnosis and effective disease management, making them valuable for large population screenings and routine surveillance programs.

“The Asia Pacific region is expected to witness the highest growth rate during the forecast period.”

The Asia Pacific is set to experience the highest growth in the veterinary infectious disease diagnostics market due to various demographic, economic, and healthcare factors. The region’s large livestock population drives the demand for accurate diagnostics to address rising infectious diseases like foot-and-mouth disease and avian influenza. Additionally, the increasing number of companion animals, especially in urban areas of China and India, is boosting veterinary healthcare spending. Enhanced veterinary infrastructure, heightened awareness of zoonotic threats, and investments in animal health are also contributing to market growth. Companies are expanding their presence in the region to improve access to advanced diagnostic technologies.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
• By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

• By End User: Veterinary Reference Laboratories (40%), Veterinary Hospitals & Clinics (25%), POC/In-house Testing (20%), and Veterinary Research Institutes & Universities (15%)
• By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
• By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Research Coverage

The market study covers the veterinary infectious disease diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

• Analysis of key drivers (growth in companion animal population, increasing demand for animal-derived food products, growing concerns about infectious zoonotic diseases, rising demand for pet insurance and growing animal health expenditures, increasing number of veterinary practitioners and rising income levels in developed markets, and growing focus on disease control and prevention measures), restraints (rising pet care costs and high cost of veterinary diagnostic tests), opportunities (growth potential of emerging economies and integration of AI and ML), and challenges (low animal healthcare awareness in emerging countries and shortage of veterinary practitioners in emerging economies) influencing the growth of the veterinary infectious disease diagnostics market.
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the veterinary infectious disease diagnostics market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary infectious disease diagnostic products across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary infectious disease diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary infectious disease diagnostics market.

Table of Contents

1               INTRODUCTION              47

1.1           STUDY OBJECTIVES       47

1.2           MARKET DEFINITION   47

1.3           STUDY SCOPE   47

1.3.1        MARKET SEGMENTATION & REGIONAL SCOPE 48

1.3.2        INCLUSIONS & EXCLUSIONS       49

1.3.3        YEARS CONSIDERED      49

1.4           MARKET STAKEHOLDERS            50

1.5           LIMITATIONS    50

1.6           SUMMARY OF CHANGES               50

2               RESEARCH METHODOLOGY       52

2.1           RESEARCH APPROACH  52

2.2           RESEARCH METHODOLOGY DESIGN     52

2.2.1        SECONDARY RESEARCH                53

2.2.1.1    Key data from secondary sources       54

2.2.2        PRIMARY DATA 54

2.2.2.1    Key data from primary sources           55

2.2.2.2    Key industry insights           56

2.3           MARKET SIZE ESTIMATION         58

2.3.1        BOTTOM-UP APPROACH              64

2.4           MARKET BREAKDOWN & DATA TRIANGULATION                 65

2.5           MARKET SHARE ESTIMATION    66

2.6           RESEARCH ASSUMPTIONS           66

2.7           RISK ASSESSMENT           67

2.8           RESEARCH LIMITATIONS             67

2.8.1        METHODOLOGY-RELATED LIMITATIONS           67

2.8.2        SCOPE-RELATED LIMITATIONS                 67

3               EXECUTIVE SUMMARY  68

4               PREMIUM INSIGHTS       74

4.1           VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW       74

4.2           ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT & COUNTRY (2024)              75

4.3           INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGIONAL MIX 76

4.4           VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

GEOGRAPHIC GROWTH OPPORTUNITIES            76

4.5           VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

DEVELOPED VS. EMERGING ECONOMIES             77

5               MARKET OVERVIEW       78

5.1           MARKET DYNAMICS       78

5.1.1        DRIVERS               79

5.1.1.1    Growth in companion animal population         79

5.1.1.2    Increasing demand for animal-derived food products    81

5.1.1.3    Growing concerns about infectious zoonotic diseases    81

5.1.1.4    Rising demand for pet insurance and growing animal health expenditure            83

5.1.1.5    Increasing number of veterinary practitioners and rising income levels in developed markets 85

5.1.1.6    Growing focus on disease control & prevention measures                 86

5.1.2        RESTRAINTS      86

5.1.2.1    Rising pet care costs             86

5.1.2.2    High cost of veterinary diagnostic tests            87

5.1.3        OPPORTUNITIES              87

5.1.3.1    Growth potential of emerging economies         87

5.1.3.2    Integration of AI & ML        88

5.1.4        CHALLENGES    88

5.1.4.1    Low animal healthcare awareness in emerging countries                 88

5.1.4.2    Shortage of veterinary practitioners in emerging economies                 88

5.2           INDUSTRY TRENDS         89

5.2.1        ADOPTION OF MULTIPLE TEST PANELS               89

5.2.2        OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES             90

5.2.3        GROWING SCALE OF VETERINARY BUSINESSES 90

5.3           TECHNOLOGY ANALYSIS             91

5.3.1        KEY TECHNOLOGIES     91

5.3.1.1    Portable instruments for POC diagnostic services          91

5.3.1.2    Biosensor-based diagnostic systems  91

5.3.2        ADJACENT TECHNOLOGIES       92

5.3.2.1    Wearable biosensors & remote monitoring devices        92

5.3.2.2    Rapid & sensitive veterinary diagnostic kits     92

5.3.2.3    Breath & saliva-based diagnostic tools              93

5.3.2.4    Microfluidics & Lab-on-a-chip devices             93

5.3.3        COMPLEMENTARY TECHNOLOGIES       94

5.3.3.1    AI-driven diagnostic platforms           94

5.3.3.2    Next-generation sequencing (NGS) 94

5.4           PORTER’S FIVE FORCES ANALYSIS           95

5.4.1        THREAT OF NEW ENTRANTS      96

5.4.2        THREAT OF SUBSTITUTES          96

5.4.3        BARGAINING POWER OF SUPPLIERS       97

5.4.4        BARGAINING POWER OF BUYERS             97

5.4.5        INTENSITY OF COMPETITIVE RIVALRY 97

5.5           REGULATORY ANALYSIS               97

5.5.1        REGULATORY LANDSCAPE         97

5.5.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             98

5.5.2.1    North America      98

5.5.2.2    Europe   99

5.5.2.3    Rest of the World 99

5.6           PATENT ANALYSIS          100

5.6.1        PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS      100

5.6.2        JURISDICTION & TOP APPLICANT ANALYSIS      102

5.7           TRADE ANALYSIS             104

5.7.1        TRADE DATA FOR HS CODE 9018              104

5.7.1.1    Import data for HS Code 9018           104

5.7.1.2    Export data for HS Code 9018            105

5.8           PRICING ANALYSIS          105

5.8.1        AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT,

2022–2024              106

5.8.2        AVERAGE SELLING PRICE, BY REGION, 2022–2024                 107

5.8.2.1    Average selling price of ELISA and PCR test kits, by region, 2024                 108

5.8.2.2    Average selling price trend of ELISA test kits (per 96-well kit),

by region, 2022–2024           108

5.8.2.3    Average selling price trend of lateral flow rapid tests (per unit),

by region, 2022–2024           109

5.8.2.4    Average selling price trend of PCR test kits (veterinary panels),

by region, 2022–2024           109

5.8.2.5   Average selling price trend of immunoassay analyzers (benchtop),

by region, 2022–2024           110

5.8.2.6    Average selling price trend of high-end immunoassay analyzers,

by region, 2022–2024           110

5.8.2.7   Average selling price trend of nucleic acid sequencers (benchtop),

by region, 2022–2024           111

5.9           REIMBURSEMENT ANALYSIS      111

5.10         KEY CONFERENCES & EVENTS, 2025–2026              112

5.11         KEY STAKEHOLDERS & BUYING CRITERIA            113

5.11.1      KEY STAKEHOLDERS IN BUYING PROCESS           113

5.11.2      BUYING CRITERIA           114

5.12         END-USER PERSPECTIVE & UNMET NEEDS          115

5.13         IMPACT OF AI ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 116

5.13.1      INTRODUCTION              116

5.13.2      MARKET POTENTIAL IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS ECOSYSTEM      116

5.13.3      AI USE CASES     117

5.13.4      KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS      117

5.14         ECOSYSTEM ANALYSIS  118

5.15         VALUE CHAIN ANALYSIS               120

5.16         SUPPLY CHAIN ANALYSIS             121

5.17         ADJACENT MARKET ANALYSIS  122

5.18         INVESTMENT & FUNDING SCENARIO     123

5.19         IMPACT OF 2025 US TARIFF ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET   124

5.19.1      INTRODUCTION              124

5.19.2      KEY TARIFF RATES          125

5.19.3      PRICE IMPACT ANALYSIS             126

5.19.4      IMPACT ON COUNTRY/REGION                127

5.19.5      IMPACT ON END-USE INDUSTRIES          129

6               VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT 130

6.1           INTRODUCTION              131

6.2           CONSUMABLES 133

6.2.1        RECURRENT PURCHASE OF DIAGNOSTIC KITS AND REAGENTS TO BOOST MARKET GROWTH            133

6.3           INSTRUMENTS 135

6.3.1        INCREASING DEMAND FOR POC ANALYZERS TO SUPPORT MARKET GROWTH     135

7               VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY        138

7.1           INTRODUCTION              139

7.2           IMMUNODIAGNOSTICS                139

7.2.1        LATERAL FLOW ASSAYS                142

7.2.1.1    Lateral flow rapid tests        146

7.2.1.1.1 Ability to provide real-time insights to drive market      146

7.2.1.2    Lateral flow strip readers     148

7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption 148

7.2.2        ELISA TESTS       150

7.2.2.1    Cost-effectiveness and ease of use to drive market         150

7.2.3        IMMUNOASSAY ANALYZERS       152

7.2.3.1    High sensitivity & specificity for biomarker detection to drive market    152

7.2.4        OTHER IMMUNODIAGNOSTIC TECHNOLOGIES                 155

7.3           MOLECULAR DIAGNOSTICS       157

7.3.1        PCR TESTS          160

7.3.1.1    Increased laboratory usage in proteomics & genomics to support growth    160

7.3.2        NUCLEIC ACID SEQUENCING    163

7.3.2.1    Growing use of nucleic acid sequencing to identify pathogens to fuel market             163

7.3.3        MICROARRAYS  165

7.3.3.1    Growing applications of biochips in identifying infectious diseases to drive market      165

7.3.4        OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES                 167

7.4           OTHER TECHNOLOGIES               169

8               VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE          171

8.1           INTRODUCTION              172

8.2           COMPANION ANIMALS 172

8.2.1        COMPANION ANIMALS MARKET, BY ANIMAL TYPE                 175

8.2.1.1    Dogs       175

8.2.1.1.1 High insurance coverage for dogs and rising disposable incomes to drive market      175

8.2.1.2    Cats         178

8.2.1.2.1 Growing pet cat population to support growth                178

8.2.1.3    Horses    180

8.2.1.3.1 Growing equine health awareness to drive market          180

8.2.1.4    Other companion animals  182

8.2.2        COMPANION ANIMALS MARKET, BY TECHNOLOGY                 184

8.2.2.1    Immunodiagnostics              184

8.2.2.1.1 Lateral flow assays                188

8.2.2.1.1.1              Rapid results, no requirement for multiple sample batches, and ease of visual reading to drive market growth           188

8.2.2.1.2 ELISA tests            190

8.2.2.1.2.1              High sensitivity, specificity, and precision of ELISA tests to drive market             190

8.2.2.1.3 Immunoassay analyzers       192

8.2.2.1.3.1              Ability to process multiple samples to drive adoption of immunoassay analyzers       192

8.2.2.1.4 Other immunodiagnostic technologies              194

8.2.2.2    Molecular diagnostics          195

8.2.2.2.1 PCR tests               198

8.2.2.2.1.1              Extensive use of PCR due to its high specificity and sensitivity to boost adoption               198

8.2.2.2.2 Nucleic acid sequencing      200

8.2.2.2.2.1              Increasing use of nucleic acid sequencing for pathogen discovery and identification to support growth                200

8.2.2.2.3 Microarrays            202

8.2.2.2.3.1              Technological advancements and increasing incidence of infectious diseases to fuel demand for microarrays    202

8.2.2.2.4 Other molecular diagnostic technologies          203

8.2.2.3    Other technologies               205

8.3           LIVESTOCK         207

8.3.1        LIVESTOCK MARKET, BY ANIMAL TYPE 210

8.3.1.1    Cattle      210

8.3.1.1.1 Growing consumption of meat to support market growth                 210

8.3.1.2    Pigs         213

8.3.1.2.1 Growing incidence of infectious diseases to drive market                 213

8.3.1.3    Poultry   215

8.3.1.3.1 Increasing demand for poultry meat to contribute to market growth    215

8.3.1.4    Other livestock     217

8.3.2        LIVESTOCK MARKET, BY TECHNOLOGY                219

8.3.2.1    Immunodiagnostics              219

8.3.2.1.1 Lateral flow assays                223

8.3.2.1.1.1              Field-readiness and stakeholder accessibility of LFAs to boost demand        223

8.3.2.1.2 ELISA tests            224

8.3.2.1.2.1              Cost-effectiveness, high sensitivity, and ease of use to drive ELISA market              224

8.3.2.1.3 Immunoassay analyzers       227

8.3.2.1.3.1              High sensitivity & specificity for biomarker detection to drive market          227

8.3.2.1.4 Other immunodiagnostic technologies              229

8.3.2.2    Molecular diagnostics          231

8.3.2.2.1 PCR tests               233

8.3.2.2.1.1              Growing use of PCR in proteomics and genomics to drive market growth             233

8.3.2.2.2 Nucleic acid sequencing      236

8.3.2.2.2.1              Identification of pathogens to fuel market        236

8.3.2.2.3 Microarrays            238

8.3.2.2.3.1              Emergence of biochips and growing applications in identifying infectious diseases to drive growth                 238

8.3.2.2.4 Other molecular diagnostic technologies          239

8.3.2.3    Other technologies               241

9               VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER 243

9.1           INTRODUCTION              244

9.2           VETERINARY REFERENCE LABORATORIES           244

9.2.1        LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET                 244

9.3           VETERINARY HOSPITALS & CLINICS       246

9.3.1        GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET             246

9.4           POINT-OF-CARE/IN-HOUSE TESTING    248

9.4.1        COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND             248

9.5           VETERINARY RESEARCH INSTITUTES & UNIVERSITIES                 250

9.5.1        INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH             250

10            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION     252

10.1         INTRODUCTION              253

10.2         NORTH AMERICA             254

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 255

10.2.2      US           262

10.2.2.1  High veterinary healthcare expenditure to drive market                 262

10.2.3      CANADA               268

10.2.3.1  Growing pet adoption to drive market              268

10.3         EUROPE               274

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      275

10.3.2      GERMANY           281

10.3.2.1  Rising awareness of zoonotic diseases to fuel market     281

10.3.3      UK          287

10.3.3.1  Increasing pet ownership to drive market         287

10.3.4      FRANCE                293

10.3.4.1  Willingness of pet owners to spend on pet health to drive market                 293

10.3.5      ITALY    299

10.3.5.1  Growing consumption of meat & dairy products to drive market                 299

10.3.6      SPAIN    305

10.3.6.1  Growing demand for poultry products to fuel market    305

10.3.7      NETHERLANDS 311

10.3.7.1  Developments in veterinary diagnostic products to support market growth       311

10.3.8      REST OF EUROPE             317

10.4         ASIA PACIFIC     322

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 324

10.4.2      CHINA  331

10.4.2.1  Increasing incidence of zoonotic diseases to propel market                 331

10.4.3      JAPAN   337

10.4.3.1  Increasing pet expenditure to support market growth    337

10.4.4      INDIA    343

10.4.4.1  Increasing demand for dairy products to drive market   343

10.4.5      AUSTRALIA         350

10.4.5.1  Rise in pet ownership to support market growth             350

10.4.6      SOUTH KOREA  356

10.4.6.1  Rising need for specialized veterinary services to drive market                 356

10.4.7      NEW ZEALAND 362

10.4.7.1  Focus on pet insurance to aid market                362

10.4.8      VIETNAM             368

10.4.8.1  Growing focus on disease surveillance to drive market  368

10.4.9      REST OF ASIA PACIFIC   374

10.5         LATIN AMERICA                379

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 380

10.5.2      BRAZIL 385

10.5.2.1  Growth in livestock industry to boost demand                 385

10.5.3      MEXICO                391

10.5.3.1  Increasing focus on poultry-associated products to support market growth       391

10.5.4      REST OF LATIN AMERICA             397

10.6         MIDDLE EAST & AFRICA                402

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 403

10.6.2      GCC COUNTRIES              409

10.6.2.1  Kingdom of Saudi Arabia (KSA)        415

10.6.2.1.1                Technological advancements in veterinary diagnostics to boost demand   415

10.6.2.2  United Arab Emirates (UAE)             420

10.6.2.2.1                Favorable government support for vet diagnostics to drive market          420

10.6.2.3  Rest of GCC Countries        426

10.6.3      REST OF MIDDLE EAST & AFRICA             431

11            COMPETITIVE LANDSCAPE         437

11.1         OVERVIEW          437

11.2         KEY PLAYER STRATEGY/RIGHT TO WIN                437

11.3         REVENUE ANALYSIS, 2020–2024  439

11.4         MARKET SHARE ANALYSIS, 2024                 439

11.4.1      MARKET SHARE ANALYSIS FOR COMPANION ANIMALS                 440

11.4.2      MARKET SHARE ANALYSIS FOR LIVESTOCK        441

11.4.3      RANKING OF KEY MARKET PLAYERS       442

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 443

11.5.1      STARS   443

11.5.2      EMERGING LEADERS     444

11.5.3      PERVASIVE PLAYERS      444

11.5.4      PARTICIPANTS 444

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         445

11.5.5.1  Company footprint               445

11.5.5.2  Region footprint   446

11.5.5.3  Product footprint  447

11.5.5.4  Technology footprint           448

11.5.5.5  Animal type footprint           449

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        450

11.6.1      PROGRESSIVE COMPANIES         450

11.6.2      RESPONSIVE COMPANIES            450

11.6.3      DYNAMIC COMPANIES  450

11.6.4      STARTING BLOCKS         450

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 452

11.6.5.1  Detailed list of key startups/SMEs    452

11.6.5.2  Competitive benchmarking of key startups      453

11.7         BRAND/PRODUCT COMPARISON             454

11.8         R&D EXPENDITURE OF KEY PLAYERS     455

11.9         COMPANY VALUATION & FINANCIAL METRICS 455

11.9.1      FINANCIAL METRICS      455

11.9.2      COMPANY VALUATION 456

11.10       COMPETITIVE SCENARIO             456

11.10.1   PRODUCT LAUNCHES & ENHANCEMENTS           456

11.10.2   DEALS  457

11.10.3   EXPANSIONS     458

11.10.4   OTHER DEVELOPMENTS              458

12            COMPANY PROFILES      459

12.1         KEY PLAYERS     459

12.1.1      IDEXX LABORATORIES, INC.       459

12.1.1.1  Business overview 459

12.1.1.2  Products & services offered                 460

12.1.1.3  Recent developments           464

12.1.1.3.1                Product/Service launches & enhancements     464

12.1.1.4  MnM view              465

12.1.1.4.1                Key strengths        465

12.1.1.4.2                Strategic choices   465

12.1.1.4.3                Weaknesses & competitive threats     466

12.1.2      ZOETIS SERVICES LLC    467

12.1.2.1  Business overview 467

12.1.2.2  Products & services offered                 468

12.1.2.3  Recent developments           470

12.1.2.3.1                Product enhancements        470

12.1.2.3.2                Deals      470

12.1.2.3.3                Expansions             471

12.1.2.4  MnM view              471

12.1.2.4.1                Key strengths        471

12.1.2.4.2                Strategic choices   472

12.1.2.4.3                Weaknesses & competitive threats     472

12.1.3      THERMO FISHER SCIENTIFIC INC.            473

12.1.3.1  Business overview 473

12.1.3.2  Products & services offered                 474

12.1.3.3  MnM view              480

12.1.3.3.1                Key strengths        480

12.1.3.3.2                Strategic choices   480

12.1.3.3.3                Weaknesses & competitive threats     480

12.1.4      VIRBAC 481

12.1.4.1  Business overview 481

12.1.4.2  Products & services offered                 482

12.1.4.3  Recent developments           483

12.1.4.3.1                Deals      483

12.1.4.3.2                Expansions             483

12.1.4.4  MnM view              484

12.1.4.4.1                Key strengths        484

12.1.4.4.2                Strategic choices   484

12.1.4.4.3                Weaknesses & competitive threats     484

12.1.5      BIOMÉRIEUX     485

12.1.5.1  Business overview 485

12.1.5.2  Products & services offered                 486

12.1.5.3  Recent developments           487

12.1.5.3.1                Product launches & approvals            487

12.1.5.4  MnM view              487

12.1.5.4.1                Key strengths        487

12.1.5.4.2                Strategic choices   487

12.1.5.4.3                Weaknesses & competitive threats     488

12.1.6      ANTECH DIAGNOSTICS, INC.     489

12.1.6.1  Business overview 489

12.1.6.2  Products & services offered                 489

12.1.6.3  Recent developments           490

12.1.6.3.1                Product launches  490

12.1.6.3.2                Expansions             491

12.1.7      INNOVATIVE DIAGNOSTICS       492

12.1.7.1  Business overview 492

12.1.7.2  Products & services offered                 492

12.1.8      NEOGEN CORPORATION              500

12.1.8.1  Business overview 500

12.1.8.2  Products & services offered                 501

12.1.8.2.1                Other developments             502

12.1.9      INDICAL BIOSCIENCE GMBH      503

12.1.9.1  Business overview 503

12.1.9.2  Products & services offered                 503

12.1.9.3  Recent developments           505

12.1.9.3.1                Product enhancements        505

12.1.10   AGROLABO S.P.A.             506

12.1.10.1                 Business overview 506

12.1.10.2                 Products & services offered                 506

12.1.11   BIONOTE             510

12.1.11.1                 Business overview 510

12.1.11.2                 Products & services offered                 510

12.1.11.3                 Recent developments           512

12.1.11.4                 Product launches  512

12.1.11.4.1             Deals      513

12.1.12   BIOGAL                514

12.1.12.1                 Business overview 514

12.1.12.2                 Products & services offered                 514

12.1.13   BIOCHEK             516

12.1.13.1                 Business overview 516

12.1.13.2                 Products & services offered                 516

12.1.13.3                 Recent developments           519

12.1.13.3.1             Product launches  519

12.1.13.3.2             Deals      519

12.1.14   MEGACOR DIAGNOSTIK GMBH 520

12.1.14.1                 Business overview 520

12.1.14.2                 Products & services offered                 520

12.1.14.3                 Recent developments           526

12.1.14.3.1             Product launches & enhancements    526

12.1.15   BIO-RAD LABORATORIES, INC.  527

12.1.15.1                 Business overview 527

12.1.15.2                 Products & services offered                 528

12.2         OTHER PLAYERS              530

12.2.1      FASSISI, GMBH  530

12.2.2      BIOTANGENTS LIMITED               531

12.2.3      SKYER, INC.        531

12.2.4      BIOPANDA REAGENTS LTD.        532

12.2.5      SHENZHEN BIOEASY BIOTECHNOLOGY, INC.     533

12.2.6      GOLD STANDARD DIAGNOSTICS             534

12.2.7      BIO-X DIAGNOSTICS S.A.              535

12.2.8      DEMEDITEC DIAGNOSTICS GMBH           536

12.2.9      EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG                 537

12.2.10   BIOSTONE ANIMAL HEALTH      538

13            APPENDIX           539

13.1         DISCUSSION GUIDE        539

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                544

13.3         RELATED REPORTS         546

13.4         AUTHOR DETAILS           547

LIST OF TABLES

TABLE 1                STANDARD CURRENCY CONVERSION RATES (USD)    50

TABLE 2                VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

ASSUMPTIONS ANALYSIS             66

TABLE 3                VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

RISK ASSESSMENT ANALYSIS      67

TABLE 4                NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024,

BY ANIMAL TYPE (MILLIONS)    79

TABLE 5                ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)                 82

TABLE 6                AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023                 84

TABLE 7                NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION)      85

TABLE 8                VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS                 95

TABLE 9                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 98

TABLE 10              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           99

TABLE 11              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 99

TABLE 12              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: MAJOR PATENTS            103

TABLE 13             IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSAND)      104

TABLE 14              EXPORT DATA FOR HS CODE 901890, BY COUNTRY,

2020–2023 (USD THOUSAND)      105

TABLE 15              AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024            106

TABLE 16              AVERAGE SELLING PRICE TREND OF ELISA TEST KITS (PER 96-WELL KIT),

BY REGION, 2022–2024    108

TABLE 17              AVERAGE SELLING PRICE TREND OF LATERAL FLOW RAPID TESTS (PER UNIT),

BY REGION, 2022–2024    109

TABLE 18              AVERAGE SELLING PRICE TREND OF PCR TEST KITS (VETERINARY PANELS),

BY REGION, 2022–2024    109

TABLE 19              AVERAGE SELLING PRICE TREND OF IMMUNOASSAY ANALYZER (BENCHTOP),

BY REGION, 2022–2024    110

TABLE 20              AVERAGE SELLING PRICE TREND OF HIGH-END IMMUNOASSAY ANALYZERS,

BY REGION, 2022–2024    110

TABLE 21              AVERAGE SELLING PRICE TREND OF NUCLEIC ACID SEQUENCERS (BENCHTOP)

BY REGION, 2022–2024    111

TABLE 22              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026        112

TABLE 23              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS (%) 113

TABLE 24              KEY BUYING CRITERIA FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS                115

TABLE 25              KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS          118

TABLE 26              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

ROLE OF COMPANIES IN ECOSYSTEM    119

TABLE 27              US-ADJUSTED RECIPROCAL TARIFF RATES                 125

TABLE 28              KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS         125

TABLE 29              NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS         127

TABLE 30              EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 127

TABLE 31              ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS          128

TABLE 32              LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS         129

TABLE 33              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            131

TABLE 34              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            132

TABLE 35              KEY PLAYERS OFFERING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC CONSUMABLES       134

TABLE 36              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CONSUMABLES,

BY COUNTRY, 2023–2030 (USD MILLION)               135

TABLE 37              KEY PLAYERS PROVIDING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC INSTRUMENTS         136

TABLE 38              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INSTRUMENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 39              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            139

TABLE 40              KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES                140

TABLE 41              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            141

TABLE 42              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)     142

TABLE 43              KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS 143

TABLE 44              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2023–2030 (THOUSAND UNITS)                143

TABLE 45              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            144

TABLE 46              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)     145

TABLE 47              KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS     146

TABLE 48              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW RAPID TESTS, BY COUNTRY, 2023–2030 (USD MILLION)     147

TABLE 49              KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS                 148

TABLE 50              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW STRIP READERS, BY COUNTRY, 2023–2030 (USD MILLION)               149

TABLE 51              KEY PLAYERS PROVIDING ELISA TESTS 150

TABLE 52              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS,

BY REGION, 2023–2030 (THOUSAND UNITS)         151

TABLE 53              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS,

BY COUNTRY, 2023–2030 (USD MILLION)               152

TABLE 54              KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS        153

TABLE 55              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2023–2030 (THOUSAND UNITS)                153

TABLE 56              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)     154

TABLE 57              KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES                155

TABLE 58              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)                 156

TABLE 59              KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC TESTS       157

TABLE 60              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                158

TABLE 61              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)     159

TABLE 62              KEY PLAYERS PROVIDING PCR TESTS    160

TABLE 63              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS,

BY REGION, 2023–2030 (THOUSAND UNITS)         161

TABLE 64              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS,

BY COUNTRY, 2023–2030 (USD MILLION)               162

TABLE 65              KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING    163

TABLE 66              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY REGION, 2023–2030 (THOUSAND UNITS)                163

TABLE 67              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)     164

TABLE 68              KEY PLAYERS PROVIDING MICROARRAYS                 165

TABLE 69              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS,

BY REGION, 2023–2030 (THOUSAND UNITS)         165

TABLE 70              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               166

TABLE 71              KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES  167

TABLE 72              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 73              KEY PLAYERS PROVIDING OTHER TECHNOLOGIES               169

TABLE 74              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)     170

TABLE 75              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            172

TABLE 76              KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR COMPANION ANIMALS              173

TABLE 77              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)     174

TABLE 78              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            175

TABLE 79              KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR DOGS 176

TABLE 80              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS,

BY COUNTRY, 2023–2030 (USD MILLION)               177

TABLE 81              KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATS  178

TABLE 82              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS,

BY COUNTRY, 2023–2030 (USD MILLION)               179

TABLE 83              KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR HORSES             180

TABLE 84              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES,

BY COUNTRY, 2023–2030 (USD MILLION)               181

TABLE 85              KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER COMPANION ANIMALS                 182

TABLE 86              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)     183

TABLE 87              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            184

TABLE 88              KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS              185

TABLE 89              COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            186

TABLE 90              COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            187

TABLE 91              KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR COMPANION ANIMALS        188

TABLE 92              COMPANION ANIMALS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY,

2023–2030 (USD MILLION)            189

TABLE 93              KEY PLAYERS PROVIDING ELISA TESTS FOR COMPANION ANIMALS 190

TABLE 94              COMPANION ANIMALS MARKET FOR ELISA TESTS, BY COUNTRY,

2023–2030 (USD MILLION)            191

TABLE 95              KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR COMPANION ANIMALS               192

TABLE 96              COMPANION ANIMALS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)            193

TABLE 97              KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS              194

TABLE 98              COMPANION ANIMALS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)       195

TABLE 99              KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR COMPANION ANIMALS          196

TABLE 100            COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            196

TABLE 101            COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)            197

TABLE 102            KEY PLAYERS PROVIDING PCR TESTS FOR COMPANION ANIMALS 198

TABLE 103            COMPANION ANIMALS MARKET FOR PCR TESTS, BY COUNTRY,

2023–2030 (USD MILLION)            199

TABLE 104            KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR COMPANION ANIMALS           200

TABLE 105            COMPANION ANIMALS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)                 201

TABLE 106            KEY PLAYERS PROVIDING MICROARRAYS FOR COMPANION ANIMALS 202

TABLE 107            COMPANION ANIMALS MARKET FOR MICROARRAYS, BY COUNTRY,

2023–2030 (USD MILLION)            203

TABLE 108            KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS                 204

TABLE 109            COMPANION ANIMALS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)            204

TABLE 110            KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR COMPANION ANIMALS     205

TABLE 111            COMPANION ANIMALS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY,

2023–2030 (USD MILLION)            206

TABLE 112            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR LIVESTOCK     208

TABLE 113            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK,

BY COUNTRY, 2023–2030 (USD MILLION)               209

TABLE 114            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TYPE, 2023–2030 (USD MILLION)         210

TABLE 115            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATTLE             211

TABLE 116            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 117            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR PIGS   213

TABLE 118            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023–2030 (USD MILLION)            214

TABLE 119            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR POULTRY         215

TABLE 120            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               216

TABLE 121            KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER LIVESTOCK ANIMALS 217

TABLE 122            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)            218

TABLE 123            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     219

TABLE 124            KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK                 220

TABLE 125            LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            221

TABLE 126            LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            222

TABLE 127            KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR LIVESTOCK               223

TABLE 128            LIVESTOCK MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY,

2023–2030 (USD MILLION)            224

TABLE 129            KEY PLAYERS PROVIDING ELISA TESTS FOR LIVESTOCK         225

TABLE 130            LIVESTOCK MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)     226

TABLE 131            KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR LIVESTOCK      227

TABLE 132            LIVESTOCK MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY,

2023–2030 (USD MILLION)            228

TABLE 133            KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK                 229

TABLE 134            LIVESTOCK MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES,

BY COUNTRY, 2023–2030 (USD MILLION)               230

TABLE 135            KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR LIVESTOCK 231

TABLE 136            LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            232

TABLE 137            LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY,

2023–2030 (USD MILLION)            233

TABLE 138            KEY PLAYERS PROVIDING PCR TESTS FOR LIVESTOCK         234

TABLE 139            LIVESTOCK MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)     235

TABLE 140            KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR LIVESTOCK  236

TABLE 141            LIVESTOCK MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY,

2023–2030 (USD MILLION)            237

TABLE 142            KEY PLAYERS PROVIDING MICROARRAYS FOR LIVESTOCK         238

TABLE 143            LIVESTOCK MARKET FOR MICROARRAYS, BY COUNTRY,

2023–2030 (USD MILLION)            239

TABLE 144            KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK                 240

TABLE 145            LIVESTOCK MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES,

BY COUNTRY, 2023–2030 (USD MILLION)               240

TABLE 146            KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR LIVESTOCK            241

TABLE 147            LIVESTOCK MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY,

2023–2030 (USD MILLION)            242

TABLE 148            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,

2023–2030 (USD MILLION)            244

TABLE 149            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 245

TABLE 150            BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US, 2023 (USD)  246

TABLE 151            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)            247

TABLE 152            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)     249

TABLE 153            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY,

2023–2030 (USD MILLION)            251

TABLE 154            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION,

2023–2030 (USD MILLION)            254

TABLE 155            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               256

TABLE 156            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               257

TABLE 157            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     257

TABLE 158            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)         257

TABLE 159            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)         258

TABLE 160            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          258

TABLE 161            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       258

TABLE 162            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         259

TABLE 163            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)     259

TABLE 164            NORTH AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         259

TABLE 165            NORTH AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 260

TABLE 166            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)            260

TABLE 167            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            260

TABLE 168            NORTH AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 261

TABLE 169            NORTH AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 261

TABLE 170            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               262

TABLE 171            US: KEY MACROINDICATORS     263

TABLE 172            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            263

TABLE 173            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            263

TABLE 174            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            264

TABLE 175            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            264

TABLE 176            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                264

TABLE 177            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            265

TABLE 178            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            265

TABLE 179            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            265

TABLE 180            US: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            266

TABLE 181            US: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 266

TABLE 182            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TYPE, 2023–2030 (USD MILLION)         266

TABLE 183            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     267

TABLE 184            US: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            267

TABLE 185            US: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            267

TABLE 186            US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            268

TABLE 187            CANADA: KEY MACROINDICATORS         269

TABLE 188            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            269

TABLE 189            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     269

TABLE 190            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            270

TABLE 191            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            270

TABLE 192            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                270

TABLE 193            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            271

TABLE 194            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            271

TABLE 195            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            271

TABLE 196            CANADA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         272

TABLE 197            CANADA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         272

TABLE 198            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 272

TABLE 199            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            273

TABLE 200            CANADA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            273

TABLE 201            CANADA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            273

TABLE 202            CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            274

TABLE 203            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            275

TABLE 204            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            276

TABLE 205            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     276

TABLE 206            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            276

TABLE 207            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            277

TABLE 208            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                277

TABLE 209            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            277

TABLE 210            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            278

TABLE 211            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            278

TABLE 212            EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 278

TABLE 213            EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         279

TABLE 214            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 279

TABLE 215            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            279

TABLE 216            EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            280

TABLE 217            EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            280

TABLE 218            EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            281

TABLE 219            GERMANY: KEY MACROINDICATORS      282

TABLE 220            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               282

TABLE 221            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     282

TABLE 222            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            283

TABLE 223            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            283

TABLE 224            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                283

TABLE 225            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            284

TABLE 226            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            284

TABLE 227            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            284

TABLE 228            GERMANY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            285

TABLE 229            GERMANY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         285

TABLE 230            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 285

TABLE 231            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            286

TABLE 232            GERMANY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            286

TABLE 233            GERMANY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            286

TABLE 234            GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               287

TABLE 235            UK: KEY MACROINDICATORS     288

TABLE 236            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            288

TABLE 237            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            289

TABLE 238            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            289

TABLE 239            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            289

TABLE 240            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                290

TABLE 241            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            290

TABLE 242            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            290

TABLE 243            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            291

TABLE 244            UK: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            291

TABLE 245            UK: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 291

TABLE 246            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TYPE, 2023–2030 (USD MILLION)         292

TABLE 247            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     292

TABLE 248            UK: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            292

TABLE 249            UK: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            293

TABLE 250            UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            293

TABLE 251            FRANCE: KEY MACROINDICATORS          294

TABLE 252            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            294

TABLE 253            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     294

TABLE 254            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            295

TABLE 255            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            295

TABLE 256            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                295

TABLE 257            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            296

TABLE 258            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            296

TABLE 259            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            296

TABLE 260            FRANCE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 297

TABLE 261            FRANCE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         297

TABLE 262            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 297

TABLE 263            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            298

TABLE 264            FRANCE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            298

TABLE 265            FRANCE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            298

TABLE 266            FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            299

TABLE 267            ITALY: KEY MACROINDICATORS               300

TABLE 268            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            300

TABLE 269            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            300

TABLE 270            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            301

TABLE 271            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            301

TABLE 272            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                301

TABLE 273            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            302

TABLE 274            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            302

TABLE 275            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            302

TABLE 276            ITALY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 303

TABLE 277            ITALY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 303

TABLE 278            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 303

TABLE 279            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            304

TABLE 280            ITALY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            304

TABLE 281            ITALY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            304

TABLE 282            ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            305

TABLE 283            SPAIN: KEY MACROINDICATORS               306

TABLE 284            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            306

TABLE 285            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     306

TABLE 286            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            307

TABLE 287            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            307

TABLE 288            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                307

TABLE 289            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            308

TABLE 290            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            308

TABLE 291            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            308

TABLE 292            SPAIN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 309

TABLE 293            SPAIN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 309

TABLE 294            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 309

TABLE 295            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            310

TABLE 296            SPAIN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 297            SPAIN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 298            SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            311

TABLE 299            NETHERLANDS: KEY MACROINDICATORS                 312

TABLE 300            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)             312

TABLE 301            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     312

TABLE 302            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)         313

TABLE 303            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)         313

TABLE 304            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          313

TABLE 305            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       314

TABLE 306            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         314

TABLE 307            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)     314

TABLE 308            NETHERLANDS: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         315

TABLE 309            NETHERLANDS: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 315

TABLE 310            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)            315

TABLE 311            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            316

TABLE 312            NETHERLANDS: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            316

TABLE 313            NETHERLANDS: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 316

TABLE 314            NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               317

TABLE 315            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               317

TABLE 316            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     318

TABLE 317            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)         318

TABLE 318            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)         318

TABLE 319            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          319

TABLE 320            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       319

TABLE 321            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         319

TABLE 322            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)     320

TABLE 323            REST OF EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         320

TABLE 324            REST OF EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 320

TABLE 325            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)            321

TABLE 326            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            321

TABLE 327            REST OF EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 321

TABLE 328            REST OF EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 322

TABLE 329            REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               322

TABLE 330            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               326

TABLE 331            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               326

TABLE 332            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     326

TABLE 333            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)         327

TABLE 334            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)         327

TABLE 335            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          327

TABLE 336            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       328

TABLE 337            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         328

TABLE 338            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)     328

TABLE 339            ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         329

TABLE 340            ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         329

TABLE 341            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)            329

TABLE 342            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            330

TABLE 343            ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            330

TABLE 344            ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 330

TABLE 345            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            331

TABLE 346            CHINA: KEY MACROINDICATORS             332

TABLE 347            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            332

TABLE 348            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     332

TABLE 349            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            333

TABLE 350            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            333

TABLE 351            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                333

TABLE 352            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            334

TABLE 353            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            334

TABLE 354            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            334

TABLE 355            CHINA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 335

TABLE 356            CHINA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 335

TABLE 357            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 335

TABLE 358            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            336

TABLE 359            CHINA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            336

TABLE 360            CHINA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            336

TABLE 361            CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            337

TABLE 362            JAPAN: KEY MACROINDICATORS              338

TABLE 363            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            338

TABLE 364            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            339

TABLE 365            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            339

TABLE 366            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            339

TABLE 367            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                340

TABLE 368            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            340

TABLE 369            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            340

TABLE 370            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            341

TABLE 371            JAPAN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 341

TABLE 372            JAPAN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 341

TABLE 373            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 342

TABLE 374            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            342

TABLE 375            JAPAN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            342

TABLE 376            JAPAN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            343

TABLE 377            JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            343

TABLE 378            INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 345

TABLE 379            INDIA: KEY MACROINDICATORS               345

TABLE 380            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            345

TABLE 381            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            346

TABLE 382            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            346

TABLE 383            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            346

TABLE 384            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                347

TABLE 385            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            347

TABLE 386            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            347

TABLE 387            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            348

TABLE 388            INDIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 348

TABLE 389            INDIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 348

TABLE 390            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 349

TABLE 391            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            349

TABLE 392            INDIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            349

TABLE 393            INDIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          350

TABLE 394            INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            350

TABLE 395            AUSTRALIA: KEY MACROINDICATORS   351

TABLE 396            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               351

TABLE 397            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     351

TABLE 398            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            352

TABLE 399            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            352

TABLE 400            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                352

TABLE 401            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            353

TABLE 402            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            353

TABLE 403            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            353

TABLE 404            AUSTRALIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            354

TABLE 405            AUSTRALIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         354

TABLE 406            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 354

TABLE 407            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            355

TABLE 408            AUSTRALIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            355

TABLE 409            AUSTRALIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            355

TABLE 410            AUSTRALIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               356

TABLE 411            SOUTH KOREA: KEY MACROINDICATORS                 356

TABLE 412            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               357

TABLE 413            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     357

TABLE 414            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)         357

TABLE 415            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)         358

TABLE 416            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          358

TABLE 417            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       358

TABLE 418            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         359

TABLE 419            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)     359

TABLE 420            SOUTH KOREA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         359

TABLE 421            SOUTH KOREA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 360

TABLE 422            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)            360

TABLE 423            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            360

TABLE 424            SOUTH KOREA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            361

TABLE 425            SOUTH KOREA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 361

TABLE 426            SOUTH KOREA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            362

TABLE 427            NEW ZEALAND: KEY MACROINDICATORS                 362

TABLE 428            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               363

TABLE 429            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     363

TABLE 430            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)         363

TABLE 431            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)         364

TABLE 432            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          364

TABLE 433            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       364

TABLE 434            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         365

TABLE 435            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)     365

TABLE 436            NEW ZEALAND: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         365

TABLE 437            NEW ZEALAND: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 366

TABLE 438            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)            366

TABLE 439            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            366

TABLE 440            NEW ZEALAND: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            367

TABLE 441            NEW ZEALAND: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 367

TABLE 442            NEW ZEALAND: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               368

TABLE 443            VIETNAM: KEY MACROINDICATORS       368

TABLE 444            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            369

TABLE 445            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     369

TABLE 446            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            369

TABLE 447            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            370

TABLE 448            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                370

TABLE 449            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            370

TABLE 450            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            371

TABLE 451            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            371

TABLE 452            VIETNAM: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 371

TABLE 453            VIETNAM: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         372

TABLE 454            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 372

TABLE 455            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            372

TABLE 456            VIETNAM: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            373

TABLE 457            VIETNAM: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            373

TABLE 458            VIETNAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               373

TABLE 459            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            374

TABLE 460            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            374

TABLE 461            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 375

TABLE 462            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)           375

TABLE 463            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          375

TABLE 464            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            376

TABLE 465            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 376

TABLE 466            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            376

TABLE 467            REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            377

TABLE 468            REST OF ASIA PACIFIC: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 377

TABLE 469            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)         377

TABLE 470            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)     378

TABLE 471            REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            378

TABLE 472            REST OF ASIA PACIFIC: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         378

TABLE 473            REST OF ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            379

TABLE 474            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               380

TABLE 475            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               380

TABLE 476            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     381

TABLE 477            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)         381

TABLE 478            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)         381

TABLE 479            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          382

TABLE 480            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       382

TABLE 481            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         382

TABLE 482            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)     383

TABLE 483            LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         383

TABLE 484            LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 383

TABLE 485            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)            384

TABLE 486            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            384

TABLE 487            LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            384

TABLE 488            LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 385

TABLE 489            LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               385

TABLE 490            BRAZIL: KEY MACROINDICATORS            386

TABLE 491            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            386

TABLE 492            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     386

TABLE 493            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            387

TABLE 494            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            387

TABLE 495            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                387

TABLE 496            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            388

TABLE 497            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            388

TABLE 498            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            388

TABLE 499            BRAZIL: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 389

TABLE 500            BRAZIL: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 389

TABLE 501            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 389

TABLE 502            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            390

TABLE 503            BRAZIL: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            390

TABLE 504            BRAZIL: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            390

TABLE 505            BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            391

TABLE 506            MEXICO: KEY MACROINDICATORS          391

TABLE 507            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            392

TABLE 508            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     392

TABLE 509            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            392

TABLE 510            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)            393

TABLE 511            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                393

TABLE 512            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            393

TABLE 513            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)            394

TABLE 514            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            394

TABLE 515            MEXICO: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 394

TABLE 516            MEXICO: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 395

TABLE 517            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION) 395

TABLE 518            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            395

TABLE 519            MEXICO: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            396

TABLE 520            MEXICO: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            396

TABLE 521            MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            397

TABLE 522            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            397

TABLE 523            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            398

TABLE 524            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 398

TABLE 525            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)           398

TABLE 526            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          399

TABLE 527            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            399

TABLE 528            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 399

TABLE 529            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY,

2023–2030 (USD MILLION)            400

TABLE 530            REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)       400

TABLE 531            REST OF LATIN AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            400

TABLE 532            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)         401

TABLE 533            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)     401

TABLE 534            REST OF LATIN AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         401

TABLE 535            REST OF LATIN AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         402

TABLE 536            REST OF LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            402

TABLE 537            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)            404

TABLE 538            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            404

TABLE 539            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            404

TABLE 540            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 405

TABLE 541            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)           405

TABLE 542            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          405

TABLE 543            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            406

TABLE 544            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 406

TABLE 545            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)            406

TABLE 546            MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            407

TABLE 547            MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 407

TABLE 548            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)         407

TABLE 549            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)     408

TABLE 550            MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, B

Y TYPE, 2023–2030 (USD MILLION)            408

TABLE 551            MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         408

TABLE 552            MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            409

TABLE 553            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               409

TABLE 554            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               410

TABLE 555            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     410

TABLE 556            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)         410

TABLE 557            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)         411

TABLE 558            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          411

TABLE 559            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       411

TABLE 560            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)         412

TABLE 561            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)     412

TABLE 562            GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         412

TABLE 563            GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 413

TABLE 564            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)            413

TABLE 565            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)            413

TABLE 566            GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 414

TABLE 567            GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 414

TABLE 568            GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,

BY END USER, 2023–2030 (USD MILLION)               414

TABLE 569            KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS      415

TABLE 570            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            415

TABLE 571            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            416

TABLE 572            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 416

TABLE 573            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)           416

TABLE 574            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          417

TABLE 575            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            417

TABLE 576            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 417

TABLE 577            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY,

2023–2030 (USD MILLION)            418

TABLE 578            KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)       418

TABLE 579            KINGDOM OF SAUDI ARABIA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            418

TABLE 580            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)         419

TABLE 581            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)     419

TABLE 582            KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         419

TABLE 583            KINGDOM OF SAUDI ARABIA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 420

TABLE 584            KINGDOM OF SAUDI ARABIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            420

TABLE 585            UNITED ARAB EMIRATES: KEY MACROINDICATORS      421

TABLE 586            UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            421

TABLE 587            UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            421

TABLE 588            UNITED ARAB EMIRATES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 422

TABLE 589            UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)           422

TABLE 590            UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          422

TABLE 591            UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            423

TABLE 592            UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 423

TABLE 593            UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY,

2023–2030 (USD MILLION)            423

TABLE 594            UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)       424

TABLE 595            UNITED ARAB EMIRATES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            424

TABLE 596            UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)         424

TABLE 597            UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)     425

TABLE 598            UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         425

TABLE 599            UNITED ARAB EMIRATES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         425

TABLE 600            UNITED ARAB EMIRATES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            426

TABLE 601            REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            426

TABLE 602            REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            427

TABLE 603            REST OF GCC COUNTRIES : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)                 427

TABLE 604            REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)           427

TABLE 605            REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          428

TABLE 606            REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            428

TABLE 607            REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 428

TABLE 608            REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY,

2023–2030 (USD MILLION)            429

TABLE 609            REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)       429

TABLE 610            REST OF GCC COUNTRIES: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            429

TABLE 611            REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)         430

TABLE 612            REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)     430

TABLE 613            REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS,

BY TYPE, 2023–2030 (USD MILLION)         430

TABLE 614            REST OF GCC COUNTRIES: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            431

TABLE 615            REST OF GCC COUNTRIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            431

TABLE 616            REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            432

TABLE 617            REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            432

TABLE 618            REST OF MIDDLE EAST & AFRICA : VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE,

2023–2030 (USD MILLION)            432

TABLE 619            REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)           433

TABLE 620            REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)          433

TABLE 621            REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            433

TABLE 622            REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)                 434

TABLE 623            REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY,

2023–2030 (USD MILLION)            434

TABLE 624            REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)       434

TABLE 625            REST OF MIDDLE EAST & AFRICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            435

TABLE 626            REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)         435

TABLE 627            REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)     435

TABLE 628            REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)            436

TABLE 629            REST OF MIDDLE EAST & AFRICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 436

TABLE 630            REST OF MIDDLE EAST & AFRICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)            436

TABLE 631            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET               437

TABLE 632            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS: DEGREE OF COMPETITION           440

TABLE 633            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR

LIVESTOCK: DEGREE OF COMPETITION               441

TABLE 634            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGION FOOTPRINT   446

TABLE 635            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PRODUCT FOOTPRINT               447

TABLE 636            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

TECHNOLOGY FOOTPRINT        448

TABLE 637            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

ANIMAL TYPE FOOTPRINT          449

TABLE 638            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

DETAILED LIST OF KEY STARTUPS/SMES             452

TABLE 639            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

COMPETITIVE BENCHMARKING OF STARTUPS 453

TABLE 640            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025        456

TABLE 641            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

DEALS, JANUARY 2022–MAY 2025                457

TABLE 642            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

EXPANSIONS, JANUARY 2022–MAY 2025  458

TABLE 643            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025    458

TABLE 644            IDEXX LABORATORIES, INC.: COMPANY OVERVIEW          459

TABLE 645            IDEXX LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED        460

TABLE 646            IDEXX LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025   464

TABLE 647            ZOETIS SERVICES LLC: COMPANY OVERVIEW                 467

TABLE 648            ZOETIS SERVICES LLC: PRODUCTS & SERVICES OFFERED             468

TABLE 649            ZOETIS SERVICES LLC: PRODUCT ENHANCEMENTS, JANUARY 2022–MAY 2025          470

TABLE 650            ZOETIS SERVICES LLC: DEALS, JANUARY 2022–APRIL 2025           470

TABLE 651            ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022–MAY 2025   471

TABLE 652            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          473

TABLE 653            THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED        474

TABLE 654            VIRBAC: COMPANY OVERVIEW 481

TABLE 655            VIRBAC: PRODUCTS & SERVICES OFFERED                 482

TABLE 656            VIRBAC: DEALS, JANUARY 2022–MAY 2025                 483

TABLE 657            VIRBAC: EXPANSIONS, JANUARY 2022–MAY 2025                 483

TABLE 658            BIOMÉRIEUX: COMPANY OVERVIEW      485

TABLE 659            BIOMÉRIEUX: PRODUCTS & SERVICES OFFERED                 486

TABLE 660            BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025    487

TABLE 661            ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW          489

TABLE 662            ANTECH DIAGNOSTICS, INC.: PRODUCTS & SERVICES OFFERED        489

TABLE 663            ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025      490

TABLE 664            ANTECH DIAGNOSTICS, INC.: EXPANSIONS, JANUARY 2022–MAY 2025               491

TABLE 665            INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW          492

TABLE 666            INNOVATIVE DIAGNOSTICS: PRODUCTS & SERVICES OFFERED        492

TABLE 667            NEOGEN CORPORATION: COMPANY OVERVIEW          500

TABLE 668            NEOGEN CORPORATION: PRODUCTS & SERVICES OFFERED        501

TABLE 669            NEOGEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025          502

TABLE 670            INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW          503

TABLE 671            INDICAL BIOSCIENCE GMBH: PRODUCTS & SERVICES OFFERED        503

TABLE 672            INDICAL BIOSCIENCE GMBH: PRODUCT ENHANCEMENTS,

JANUARY 2022–MAY 2025               505

TABLE 673            AGROLABO S.P.A.: COMPANY OVERVIEW                 506

TABLE 674            AGROLABO S.P.A.: PRODUCTS & SERVICES OFFERED             506

TABLE 675            BIONOTE: COMPANY OVERVIEW              510

TABLE 676            BIONOTE: PRODUCTS & SERVICES OFFERED                 510

TABLE 677            BIONOTE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025   512

TABLE 678            BIONOTE: DEALS, JANUARY 2022–MAY 2025                 513

TABLE 679            BIOGAL: COMPANY OVERVIEW 514

TABLE 680            BIOGAL: PRODUCTS & SERVICES OFFERED                 514

TABLE 681            BIOCHEK: COMPANY OVERVIEW              516

TABLE 682            BIOCHEK: PRODUCTS & SERVICES OFFERED                 516

TABLE 683            BIOCHEK: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025   519

TABLE 684            BIOCHEK: DEALS, JANUARY 2022–MAY 2025                 519

TABLE 685            MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW          520

TABLE 686            MEGACOR DIAGNOSTIK GMBH: PRODUCTS & SERVICES OFFERED        520

TABLE 687            MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025                 526

TABLE 688            BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW          527

TABLE 689            BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED        528

TABLE 690            FASSISI, GMBH: COMPANY OVERVIEW   530

TABLE 691            BIOTANGENTS LIMITED: COMPANY OVERVIEW                 531

TABLE 692            SKYER, INC.: COMPANY OVERVIEW         531

TABLE 693            BIOPANDA REAGENTS LTD.: COMPANY OVERVIEW          532

TABLE 694            SHENZHEN BIOEASY BIOTECHNOLOGY, INC.: COMPANY OVERVIEW   533

TABLE 695            GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW          534

TABLE 696            BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW                 535

TABLE 697            DEMEDITEC DIAGNOSTICS GMBH: COMPANY OVERVIEW          536

TABLE 698            EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW              537

TABLE 699            BIOSTONE ANIMAL HEALTH: COMPANY OVERVIEW          538

LIST OF FIGURES

FIGURE 1              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET

SEGMENTATION & REGIONAL SCOPE    48

FIGURE 2              VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH DESIGN       52

FIGURE 3              PRIMARY SOURCES         54

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)                 56

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)                 57

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS            57

FIGURE 7              SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS         58

FIGURE 8              REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.       59

FIGURE 9              REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2024)    59

FIGURE 10            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

DEMAND-SIDE ANALYSIS             61

FIGURE 11            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2025–2030)          62

FIGURE 12            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 63

FIGURE 13            TOP-DOWN APPROACH                63

FIGURE 14            BOTTOM-UP APPROACH              64

FIGURE 15            MARKET DATA TRIANGULATION METHODOLOGY              65

FIGURE 16            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT,

2025 VS. 2030 (USD MILLION)      68

FIGURE 17            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY,

2025 VS. 2030 (USD MILLION)      69

FIGURE 18            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE,

2025 VS. 2030 (USD MILLION)      69

FIGURE 19            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2025 VS. 2030 (USD MILLION)      70

FIGURE 20            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)      70

FIGURE 21            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TYPE, 2025 VS. 2030 (USD MILLION)  71

FIGURE 22            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK,

BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)                72

FIGURE 23            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      72

FIGURE 24            GEOGRAPHIC SNAPSHOT OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET   73

FIGURE 25            INCREASING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET GROWTH  74

FIGURE 26            CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES IN 2024    75

FIGURE 27            ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD          76

FIGURE 28            CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       76

FIGURE 29            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD    77

FIGURE 30            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS,

RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         78

FIGURE 31            EUROPE: PET POPULATION, 2021–2023  80

FIGURE 32            US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)    84

FIGURE 33            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS                 95

FIGURE 34            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025)            101

FIGURE 35            TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2014–MAY 2025)            102

FIGURE 36            AVERAGE SELLING PRICE TREND FOR ELISA TEST KITS AND PCR TEST KITS,

BY KEY PLAYER, 2024      107

FIGURE 37            AVERAGE SELLING PRICE OF ELISA AND PCR TEST KITS, BY REGION, 2024        108

FIGURE 38            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS         113

FIGURE 39            KEY BUYING CRITERIA FOR TOP THREE END USERS   114

FIGURE 40            AI USE CASES     117

FIGURE 41            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

ECOSYSTEM MARKET MAP          119

FIGURE 42            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS            120

FIGURE 43            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS          122

FIGURE 44            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ADJACENT MARKETS   122

FIGURE 45            INVESTMENT AND FUNDING SCENARIO FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET PLAYERS, 2020–2024         123

FIGURE 46            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT          253

FIGURE 47            EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA,

2012–2030              255

FIGURE 48            NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT      256

FIGURE 49            ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024 323

FIGURE 50            ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024 324

FIGURE 51            ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT      325

FIGURE 52            REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020–2024)          439

FIGURE 53            MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS (2024)     440

FIGURE 54            MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK (2024)            441

FIGURE 55            RANKING OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2024         442

FIGURE 56            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024  444

FIGURE 57            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY FOOTPRINT               445

FIGURE 58            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                451

FIGURE 59            VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:

BRAND/PRODUCT COMPARATIVE ANALYSIS     454

FIGURE 60            R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2022–2024              455

FIGURE 61            EV/EBITDA OF KEY VENDORS   455

FIGURE 62            YEAR-TO-DATE (YTD) PRICE OF TOTAL RETURN AND 5-YEAR

STOCK BETA OF KEY VENDORS 456

FIGURE 63            IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)             460

FIGURE 64            ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)    468

FIGURE 65            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)             474

FIGURE 66            VIRBAC: COMPANY SNAPSHOT (2024)    482

FIGURE 67            BIOMÉRIEUX: COMPANY SNAPSHOT (2024)                 486

FIGURE 68            NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)             501

FIGURE 69            BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)             528

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧